Anebulo Pharmaceuticals Inc
ANEB
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.91M
Close$
$0.34
13% downside
Current Fair Value
13% downsideOvervalued by 13% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.91 Million |
|---|---|
| Enterprise Value | $6.86 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.25 |
| Beta | -1.87 |
| Outstanding Shares | 41,084,731 |
Return
| Return on Equity | -100.53% |
|---|---|
| Return on Assets | -84.68% |
| Return on Invested Capital | -76.17% |
Valuation & Multiples
| P/E Ratio | -2.01 |
|---|---|
| PEG | 10.67 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.02 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 23, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 54.06%▼ 11.64% |
|---|---|
| Total Invested | $22.43M▼ 59.62% |
| Investors Holding | 17▼ 3.00% |
ESG Score
No data
About Anebulo Pharmaceuticals Inc
2 employees